| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net income | -4.4 | -1.8 |
| EPS (diluted, $ a share) | $-0.19 | $-0.54 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, OTC: PALX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Palomino Laboratories Inc.: key numbers
- Share price
- $14.00Close, Nov 16
- Market cap
- $387M
- Shares outstanding
- 27.64MLatest SEC cover page
- Sector
- Manufacturing
- Industry
- Semiconductors & Related DevicesSIC 3674
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Palomino Laboratories Inc.
All →Palomino Laboratories Shareholder Meeting
Palomino Laboratories held its 2026 Annual Meeting of Stockholders on November 5, 2026. Shareholders elected three directors, ratified KNAV CPA LLP as the independent auditor, and approved an amendment to the 2025 Equity Incentive Plan to increase the share reserve to the greater of 10 million shares or 15% of outstanding common stock.
Palomino Laboratories M&A Deal with Vega Links, Inc.
Palomino Laboratories Inc. filed an amendment to provide historical audited financial statements and pro forma financial information following its acquisition of Vega Links, Inc. The acquisition was completed via a share exchange where Palomino issued 4,472,000 shares of common stock to acquire all outstanding shares of Vega Links, making it a wholly owned subsidiary.
- Counterparty
- Vega Links, Inc.